No Data
No Data
No Data
No Data
No Data
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
CHICAGO, IL / ACCESSWIRE / April 19, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,
AccesswireApr 20 04:30
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of Its Next Generation AI Drug Repurposing Platform
CHICAGO, IL / ACCESSWIRE / March 21, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,
AccesswireMar 21 21:45
Cosmos Health To Receive Regulatory Approval For C-Scrub Disinfectant In The UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU; No Financial Terms Of Purchase Order Disclosed
Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nu
BenzingaMar 19 22:13
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
Yahoo FinanceMar 19 22:10
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
CHICAGO, IL / ACCESSWIRE / March 18, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,
AccesswireMar 18 21:25
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by Over $5 Million
CHICAGO, IL / ACCESSWIRE / February 29, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
AccesswireFeb 29 22:25
No Data
No Data